Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
647
+12
+2% +$4.11K 0.01% 126
2026
Q1
$224K Buy
+635
New +$226K 0.01% 120
2025
Q1
Sell
-790
Closed -$206K 96
2024
Q4
$206K Hold
790
0.01% 105
2024
Q3
$255K Sell
790
-200
-20% -$65.4K 0.01% 90
2024
Q2
$309K Hold
990
0.02% 74
2024
Q1
$281K Hold
990
0.02% 78
2023
Q4
$285K Buy
990
+200
+25% +$54.5K 0.02% 74
2023
Q3
$212K Buy
+790
New +$197K 0.01% 89
2022
Q4
Sell
-1,228
Closed -$277K 81
2022
Q3
$277K Buy
+1,228
New +$298K 0.02% 71

Other funds holding AMGN

Index Fund Advisors's AMGN Position: Q2 2026 in Review

Index Fund Advisors increased its Amgen (AMGN) stake by 1.9% in Q2 2026, buying an estimated $4.11K and bringing the position to 647 shares worth $234K. The position accounts for 0.01% of the portfolio, ranked #126.

Index Fund Advisors first reported a position in AMGN in Q3 2022 and has held it in 9 quarters since. The position peaked at $309K in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Index Fund Advisors held 647 shares of Amgen worth $234K as of Q2 2026.
  • Index Fund Advisors bought 12 Amgen shares in Q2 2026, an estimated $4.11K.
  • Amgen made up 0.01% of Index Fund Advisors's portfolio in Q2 2026, its #126 holding.
  • Index Fund Advisors first reported a position in Amgen in Q3 2022 and has held it in 9 quarters since.
  • Index Fund Advisors's Amgen position peaked at $309K in Q2 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Index Fund Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.